FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Monday

 

14 STUDIES & ARTICLES FOR NEUROLOGISTS & NURSES PLUS PATIENTS



Gran's new lease of life thanks to mobility scooter
Lancaster Today
Despite living with Multiple Sclerosis, grandmother Brenda Escreet continues to attend numerous music festivals and gigs, support several charities and have ‘biking’ freedom outdoors thanks to her mobility scooter.


Mouse Studies Reveal Promising Vitamin D-Based Treatment for MS
 A diagnosis of multiple sclerosis (MS) is a hard lot. Patients typically get the diagnosis around age 30 after experiencing a series of neurologicalproblems. In search of a better option for MS patients, a team of University of Wisconsin-Madison biochemists has discovered a promising vitamin D-based treatment that can halt -- and even reverse -- the course of the disease in a mouse model of MS. The treatment involves giving mice that exhibit MS symptoms a single dose of calcitriol, the active hormone form of vitamin D, followed by ongoing vitamin D supplements through the diet. The protocol is described in a scientific article that was published online in August in the Journal of Neuroimmunology. "All of the animals just got better and better, and the longer we watched them, the more neurological function they regained," says biochemistry professor Colleen Hayes, who led the study.

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
 prnewswire.com

Biogen: All Reasons For Bulls To Be Happy
seekingalpha.com

CLICK ON "Read More" BELOW FOR 1O MORE STUDIES & ARTICLES IN MONDAYS NEWS




Tysabri (Natalizumab) treatment decreases serum IgM and IgG levels in multiple sclerosis patients
   Rebecca C Selter, Viola Biberacher, Verena Grummel, Dorothea Buck,
   Christian Eienbroker, Wolfgang H Oertel, Achim Berthele, Bjorn
   Tackenberg, and Bernhard Hemmer
   Multiple Sclerosis Journal. 2013;  19(11): p. 1454-1461

Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing–remitting multiple sclerosis patients 
   Sabata Martino, Simona Montesano, Ilaria di Girolamo, Roberto Tiribuzi,
   Maria Di Gregorio, Antonio Orlacchio, Alessandro Datti, Paolo
   Calabresi, Paola Sarchielli, and Aldo Orlacchio
   Multiple Sclerosis Journal. 2013;  19(11): p. 1443-1453

businesswire.com

Saskatchewan trial for MS liberation therapy cancelled, citing lack of volunteers
theglobeandmail.com



Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 
   G Comi, MA Battaglia, A Bertolotto, M Del Sette, A Ghezzi, G
   Malferrari, M Salvetti, MP Sormani, L Tesio, E Stolz, P Zaratin, G
   Mancardi, and   the CoSMo Collaborative Study Group
   Multiple Sclerosis Journal. 2013;  19(11): p. 1508-1517 Open Access

Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors 
   Kristof Thewissen, Amber H Nuyts, Nathalie Deckx, Bart Van Wijmeersch,
   Guy Nagels, Marie D'hooghe, Barbara Willekens, Patrick Cras, Bert O
   Eijnde, Herman Goossens, Viggo FI Van Tendeloo, Piet Stinissen, Zwi N
   Berneman, Niels Hellings, and Nathalie Cools
   Multiple Sclerosis Journal. published 23 September 2013,
   10.1177/1352458513505352

Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base
   Susanne Bechtold, Astrid Blaschek, Klemens Raile, Axel Dost, Clemens
   Freiberg, Meik Askenas, Elke Frohlich-Reiterer, Esther Molz, and
   Reinhard W. Holl
   Diabetes Care. published 23 September 2013, 10.2337/dc13-1414

skegnessstandard.co


Longitudinally extensive varicella-zoster virus myelitis in a patient with multiple sclerosis.
From the Departments of *Neurology; and †Radiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; and ‡Serology Section, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.: Cuello JP, Romero J, de Ory F, de Andrés C.
Spine (Phila Pa 1976). 2013 Sep 15;38(20)

To report this rare varicella-zoster virus (VZV) complication in a patient with multiple sclerosis. 
Awareness of the potentially varied presentation of VZV myelitis can enable earlier recognition and specific treatment.

Labels:



Go to Newer News Go to Older News